Skip to content
Open Menu
Search for:
News & events
Insight & resources
Facilities
Careers
Contact
Drug substance
Back to main menu
Drug substance
Custom development
Process development & validation
Analytical development & validation
Custom manufacturing
Technology transfer
Manufacturing capabilities
Generic APIs
Product catalogue
Controlled substances
High potency APIs
Specialist technologies
Biocatalysis
Continuous flow
Controlled substances
Crystallization process development
High potency APIs
Solid state science
Material characterization
Drug product
Back to main menu
Drug product
Custom development
Formulation development
Analytical development & validation
Clinical supply
Custom manufacturing
Technology transfer
Manufacturing capabilities
Packaging
Conventional dosage forms
Solid dose
Semi-solid dose
Liquids
Specialized dosage forms
Fixed-dose combinations
Pediatric
Bi-layer tablets
Stick packs
Topicals
Controlled substances
Sterile & non-sterile
Solid state science
Material characterization
Analytical services
Back to main menu
Analytical services
Compendial testing
Microbiology
Cleanroom services
Release & QC testing
Extractables/leachables studies
Stability storage
Method development & validation
Material characterization
Elemental impurities
Impurity isolation, identification & characterization
Reference standard qualification
Bioanalytical & biopharmaceutical analysis
Biopharmaceutical Testing
Open Search
News & events
News
Search news
Post date
Post Date
Tags
Tags
All Tags
About (1)
analytical services (19)
APIs (1)
biocatalysis (1)
Cambrex (3)
Careers (1)
case study (20)
cGMP (1)
Chemistry (1)
Company (2)
Compounds (1)
Continuous flow (4)
Corporate Brochure (1)
Custom Development (1)
Development (1)
Drug product (12)
Drug substance (21)
Facilities (1)
HPAPIs (1)
information sheet (11)
Literature (4)
Manufacturing (1)
Meet our experts (1)
Opioids (1)
Resources (3)
Small Molecule (1)
Video (1)
Webcasts (1)
Webinar (3)
whitepaper (4)
By author
By Author
All Authors
Cambrex (99)
Dan McGinn (5)
Hannah McLachlan (36)
Leanne Buffery (2)
Natalee Campbell (3)
Advanced search
Year:
2019
4 Dec 2019
Cambrex Announces Completion of Acquisition by the Permira Funds
14 Nov 2019
Cambrex Wins Third API Development Award at CPhI Worldwide
23 Sep 2019
Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement
7 Aug 2019
Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash
30 Jul 2019
Cambrex to Double Size of Edinburgh Solid Form Screening Facility
26 Jun 2019
Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering
25 Jun 2019
Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer
4 Jun 2019
Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site
23 Apr 2019
Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan
10 Apr 2019
Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA
Posts navigation
Older posts